References

ACGIH (American Conference of Governmental Industrial Hygienists). 2003. 2003 TLVs and BEIs. American Conference of Governmental Industrial Hygienists, Cincinnati, OH.

Andersen, M.E. 1981. A physiologically based toxicokinetic description of the metabolism of inhaled gases and vapors: Analysis at steady state. Toxicol. Appl. Pharmacol. 60(3):509-526.

Azar, A., H.J. Trochimowicz, J.B. Terrill, and L.S. Mullin. 1973. Blood levels of fluorocarbon related to cardiac sensitization. Am. Ind. Hyg. Assoc. J. 34(3):102-109.


Bannister, W., W.H. Basinger, B. Dlugogorski, P. Grossl, E. Kennedy, C. Kibert, A. Lauterbach, J. O’Bryon, G. Ober, R. Rubenstein, J. Vitali, and E. Wakayama. 2003. Critique of the Report Suitability of CF3I to Replace Halon 1301 as the Inerting Agent in Wing Fuel Tanks on the F-16 Aircraft. Prepared by Hydro Geologics, Inc, for Director of Defense Research and Engineering.

Bass, M. 1970. Sudden sniffing death. JAMA 212(12):2075-2079.

Beck, P.S., D.G. Clark, and D.J. Tinston. 1973. The pharmacologic actions of bromochlorodifluoromethane (BCF). Toxicol. Appl. Pharmacol. 24(1):20-29.

Brock, W.J., H.J. Trochimowicz, R.J. Millischer, C. Farr, T. Kawano, and G.M. Rusch. 1995. Acute and subchronic toxicity of 1,1-dichloro-1-fluoroethane (HCFC-141b). Food Chem. Toxicol. 33(6):483-490.

Brock, W.J., G.M. Rusch, and H.J. Trochimowicz. 2003. Cardiac sensitization: Methodology and interpretation in risk assessment. Regul. Toxicol. Pharmacol. 38(1):78-90.


Chaney, L.A. 2002. Toxicity Review for Iodotrifluoromethane (CF3I): 2002 Update. U.S. Army Center for Health Promotion and Preventive Medicine, Aberdeen Proving Ground, MD.

Clark, D.G., and D.J. Tinston. 1973. Correlation of the cardiac sensitizing potential of halogenated hydrocarbons with their physicochemical properties. Br. J. Pharmacol. 49(2):355-357.

Connell, P.S., D.E. Kinnison, D.J. Bergmann, K.O. Patten, D.J. Wuebbles, R.G. Daniel, C.K. Williamson, A.W. Miziolek and R.E. Huie. 1996. Environmen-



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 68
Iodotrifluoromethane: Toxicity Review References ACGIH (American Conference of Governmental Industrial Hygienists). 2003. 2003 TLVs and BEIs. American Conference of Governmental Industrial Hygienists, Cincinnati, OH. Andersen, M.E. 1981. A physiologically based toxicokinetic description of the metabolism of inhaled gases and vapors: Analysis at steady state. Toxicol. Appl. Pharmacol. 60(3):509-526. Azar, A., H.J. Trochimowicz, J.B. Terrill, and L.S. Mullin. 1973. Blood levels of fluorocarbon related to cardiac sensitization. Am. Ind. Hyg. Assoc. J. 34(3):102-109. Bannister, W., W.H. Basinger, B. Dlugogorski, P. Grossl, E. Kennedy, C. Kibert, A. Lauterbach, J. O’Bryon, G. Ober, R. Rubenstein, J. Vitali, and E. Wakayama. 2003. Critique of the Report Suitability of CF3I to Replace Halon 1301 as the Inerting Agent in Wing Fuel Tanks on the F-16 Aircraft. Prepared by Hydro Geologics, Inc, for Director of Defense Research and Engineering. Bass, M. 1970. Sudden sniffing death. JAMA 212(12):2075-2079. Beck, P.S., D.G. Clark, and D.J. Tinston. 1973. The pharmacologic actions of bromochlorodifluoromethane (BCF). Toxicol. Appl. Pharmacol. 24(1):20-29. Brock, W.J., H.J. Trochimowicz, R.J. Millischer, C. Farr, T. Kawano, and G.M. Rusch. 1995. Acute and subchronic toxicity of 1,1-dichloro-1-fluoroethane (HCFC-141b). Food Chem. Toxicol. 33(6):483-490. Brock, W.J., G.M. Rusch, and H.J. Trochimowicz. 2003. Cardiac sensitization: Methodology and interpretation in risk assessment. Regul. Toxicol. Pharmacol. 38(1):78-90. Chaney, L.A. 2002. Toxicity Review for Iodotrifluoromethane (CF3I): 2002 Update. U.S. Army Center for Health Promotion and Preventive Medicine, Aberdeen Proving Ground, MD. Clark, D.G., and D.J. Tinston. 1973. Correlation of the cardiac sensitizing potential of halogenated hydrocarbons with their physicochemical properties. Br. J. Pharmacol. 49(2):355-357. Connell, P.S., D.E. Kinnison, D.J. Bergmann, K.O. Patten, D.J. Wuebbles, R.G. Daniel, C.K. Williamson, A.W. Miziolek and R.E. Huie. 1996. Environmen-

OCR for page 68
Iodotrifluoromethane: Toxicity Review tal aspects of halon replacements: Considerations for advanced agents and the ozone depletion potential of CF3I. Pp. 585-598 in Proceedings of Halon Options Technical Working Conference May 7-9, 1996, Albuquerque, NM. Conolly, R.B., and M.E. Andersen. 1991. Biologically based pharmacodynamics models: Tools for toxicological research and risk assessment. Annu. Rev. Pharmacol. Toxicol. 31:503-523. Dalby, W. 1996. Evaluation of Toxicity of Hydrogen Fluoride at Short Exposure Times. Petroleum Environmental Research Forum Project 92-09. Stony-brook Laboratories, Inc., Pennington, NJ. Dodd, D.E., E.R. Kinkead, R.E. Wolfe, H.F. Leahy, J.H. English, and A. Vinegar. 1997. Acute and subchronic inhalation studies on trifluoroiodomethane vapor in Fischer 344 rats. Fundam. Appl. Toxicol. 35(1):64-77. Dodd, D.E., H.F. Leahy, M.L. Feldmann, A. Vinegar, and J.H. English. 1998. Reproductive Toxicity Screen of Trifluoroiodomethane (CF3I) in Sprague-Dawley Rats. NTIS/ADA367430. Air Force Research Laboratory, Wright-Patterson Air Force Base, OH. Dodd, D.E., and A. Vinegar. 1998. Cardiac sensitization testing of the halon replacement candidates trifluoroiodomethane (CF3I) and 1,1, 2,2,3,3,3-heptafluoro-1-iodopropane (C3F7I). Drug Chem. Toxicol. 21(2):137-149. Dodd, D.E., H.F. Leahy, M.L. Feldmann, J.H. English, A. Vinegar. 1999. Reproductive toxicity screen of trifluoroiodomethane (CF3I) in Sprague-Dawley rats. Inhal. Toxicol. 11(11):1041-1055. Dodd, D.E.,G.W. Jepson, and J.A. Macko, Jr. 2000. Toxicological Assessment of Human Health Consequences Associated with Inhalation of Halon Replacement Chemicals; Section II: Human Health Safety Evaluation of Halon Replacement Candidates. Final Report to the Strategic Environmental Research and Development Program. AFRL-HE-WP-TR-2000-0104. Next Generation Fire Suppression Technology Program, Building and Fire Research Laboratory, National Institute of Standards and Technology, Gaithersburg, MD. [Online]. Available: http://www.bfrl.nist.gov/866/NGP/publications/3Dodd_Human%20Health%20Safety%20Evaluatlion%20of%20Halon.pdf [accessed July 21, 2004]. Dudley, S.C., Jr. 2003. Cardiac sensitization—Mechanism and applicability to man. Paper presented to the Subcommittee on Iodotrifluoromethane, Washington, DC, October 28. EPA (U. S. Environmental Protection Agency). 1994. Risk Screen on the Use of Substitutes for Class I Ozone-Depleting Substances: Fire Suppression and Ozone Protection (Halon Substitutes). SNAP Technical Background Document. Office of Air and Radiation, U. S. Environmental Protection Agency, Washington, DC. March. Hardy, C.J., P.C. Kieran, and I.J. Sharman. 1994. Assessment of the cardiac sensitization potential (CSP) of a range of halogenated alkanes. Toxicologist 14:378. Hashimoto, K., and K. Hashimoto. 1972. The mechanism of sensitization of the ventricle to epinephrine by halothane. Am. Heart J. 83(5):652-658.

OCR for page 68
Iodotrifluoromethane: Toxicity Review Huntingdon Life Sciences Ltd. 2000. HFC 236a, HFC 227ea, HFC 125, and CF3I: An Inhalation Study to Investigate the Blood Levels of Inhaled Halocarbons in the Beagle Dog. IFP 001/984370. Prepared by Huntingdon Life Sciences, Ltd., Huntingdon, England, for ICF Incorporated, Washington, DC. June 29. ISO (International Organization for Standardization). 2004. ISO 14520: Gaseous Fire-Extinguishing Systems. Physical Properties and System Design. [Online]. Available http://www.iso.org/iso/en/StandardsQueryFormHandler. StandardsQueryFormHandler [accessed July 29, 2004]. Kenny, T.J., C.K. Shephard, and C.J. Hardy. 1995. Iodotrifluoromethane and Iodoheptafluoropropane Assessment of Cardiac Sensitization Potential in Dogs. AL/OE-TR-1995-0031. Armstrong Laboratory, Wright-Patterson Air Force Base, OH. Kinkead, E.R., S.A. Salins, R.E. Wolfe, and H.F. Leahy. 1994. Acute Toxicity Evaluation of Halon Replacement Trifluoroiodomethane (CF3I). AL/OE-TR-1994-0070. Prepared by ManTech Environmental Technology, Inc., Dayton, OH, for Armstrong Laboratory, Air Force Materiel Command, Wright-Patterson Air Force Base, OH. Kinkead, E.R., R.E. Wolfe, M.L. Feldmann, H.F. Leahy, and J.H. English. 1995. Two-week range-finding, nose-only inhalation exposure of F-344 male rats to trifluoroiodomethane (CF3I). Pp. 84-92 in 1994 Toxic Hazards Research Unit (THRU) Annual Report, D.E. Dodd, ed. AL/OE-TR-1995-0135. ManTech Environmental Technology, Inc., Dayton, OH. Kinkead, E.R., R.E. Wolfe, M.L. Feldmann, H.F. Leahy, and C.D. Flemming. 1996. 90-day Nose-Only Inhalation Toxicity Study of Trifluoroiodomethane (CF3I) in Male and Female Fisher 344 Rats. Report No. AL/OE-TR-1996-0024. Prepared by ManTech Environmental Technology, Inc., Dayton, OH, for Armstrong Laboratory, Wright-Patterson Air Force Base, OH. Koski, W.S., S. Roszak, J.J. Kaufman, and K. Balasubramanian. 1997. Potential toxicity of CF3X halocarbons. In Vitro Toxicol. 10 (4):455-457. LeBoeuf, R.A., K.A. Kerckaert, M.J. Aardema, and R.J. Isfort. 1999. Use of Syrian hamster embryo and BALB/c 3T3 cell transformation for assessing the carcinogenic potential of chemicals. Pp. 409-425 in The Use of Short-and Medium-Term Tests for Carcinogens and Data on Genetic Effects in Carcinogenic Hazard Evaluation, D.B. McGregor, J.M. Rice, and S. Venitt, eds. IARC Scientific Publications No. 146. Lyon: International Agency for Research on Cancer. Ledbetter, A. 1994. Acute Inhalation Toxicity of Iodotrifluoromethane in Rats. Final Report. Project No. 1530-001. Prepared by ManTech Environmental Technology, Research Triangle Park, NC, for New Mexico Engineering Research Institute, Albuquerque. Lee, K.P., S.R. Frame, G.P. Sykes, and R. Valentine. 1993. Testicular degeneration and spermatid retention in young male rats. Toxicol. Pathol. 21(3):292-302. Levy, A.G. 1913. The exciting causes of ventricular fibrillation in animals under chloroform anesthesia. Heart 4:319-378.

OCR for page 68
Iodotrifluoromethane: Toxicity Review Levy, A.G., and T. Lewis. 1911. Heart irregularities resulting from the inhalation of low percentages of chloroform vapour and their relationship to ventricular fibrillation. Heart 3:99-111. Malley, L.A. 1993. Subchronic Inhalation Toxicology: 90-day Study with HFC-143a in Rats. Medical Research Project No. 9336-001, Laboratory Project ID Haskell Laboratory Report No. 690-92. E.I. Du Pont de Nemours and Company, Newark, DE. McCain, W.C., and J. Macko. 1999. Toxicity Review for Iodotrifluoromethane (CF3I) May 1999. USACHPPM Project No. 85-8823-99. U.S. Army Center for Health Promotion and Preventive Medicine, Aberdeen Proving Ground, MD. [Online]. Available: http://www.bfrl.nist.gov/866/HOTWC/HOTWC2003/pubs/R9902725.pdf [accessed June 15, 2004]. Meek, W.J., H.R. Hathaway, and O.S. Orth. 1937. The effects of ether, chloroform and cyclopropane on cardiac automaticity. J. Pharmacol. Exp. Ther. 61:240-252. Mitchell, A.D. 1995a. Genetic Toxicity Evaluation of Iodotrifluoromethane (CF3I), Vol. 1. Results of the Salmonella typhimurium Histidine Reversion Assay (Ames Assay). AL/OE-TR-1995-0019. NTIS/AD-A298 926/7. Prepared by ManTech Environmental Technology, Inc., Dayton, OH, for Genesys Research, Inc., Research Triangle Park, NC. Mitchell, A.D. 1995b. Genetic Toxicity Evaluation of Iodotrifluoromethane (CF3I), Vol. 2. Results of in Vivo Mouse Bone Marrow Erythrocyte Micronucleus Testing. AL/OE-TR-1995-0009. NTIS/AD-A298 927/5. Prepared by ManTech Environmental Technology, Inc., Dayton, OH, for Genesys Research, Inc., Research Triangle Park, NC. Mitchell, A.D. 1995c. Genetic Toxicity Evaluation of Iodotrifluoromethane (CF3I), Vol. 3. Results of the Forward Mutation Assay Using L5178Y Mouse Lymphoma Cells. AL/OE-TR-1995-0009. NTIS/AD-A299 033/1. Prepared by ManTech Environmental Technology, Inc., Dayton, OH, for Genesys Research, Inc., Research Triangle Park, NC. Moore, T.A., S.R. Scaggs, M.R. Corbitt, R.E. Tapscott, D.S. Dierdorf, and C.J. Kibert. 1994. The Development of CF3I as a Halon Replacement. NMERI Report 1994/40/31790. New Mexico Engineering Research Institute, Albuquerque. Mullin, L.S., A. Azar, C.F. Reinhardt, P.E. Smith Jr., and E.F. Fabryka. 1972. Halogenated hydrocarbon-induced cardiac arrhythmias associated with release of endogenous epinephrine. Am. Ind. Hyg. Assoc. J. 33(6):389-396. Mullin, L.S., C.F. Reinhardt, and R.E. Hemingway. 1979. Cardiac arrhythmias and blood levels associated with inhalation of Halon 1301. Am. Ind. Hyg. Assoc. J. 40(7):653-658. Muir, B.J., L.W. Hall, and M.C. Littlewort. 1959. Cardiac irregularities in cats under halothane anaesthesia. Br. J. Anaesth. 31:488-489. NFPA (National Fire Protection Association). 2000. 2001 Standard on Clean Agent Fire Extinguishing Systems. National Fire Protection Association, Quincy, MA.

OCR for page 68
Iodotrifluoromethane: Toxicity Review NFPA (National Fire Protection Association). 2004. 2001-2004 Standard on Clean Agent Fire Extinguishing Systems. National Fire Protection Association, Quincy, MA. NIOSH (National Institute for Occupational Safety and Health). 1989. Preventing Death from Excessive Exposure to Chlorofluorocarbon 113 (CFC-113). NIOSH Alert. DHHS (NIOSH) 89-109. U.S. Department of Health and Human Services, National Institute for Occupational Safety and Health, Cincinnati, OH. NRC (National Research Council). 1996. Evaluation of the dog cardiac sensitization test. Pp. 13-22 in Toxicity of Alternatives to Chlorofluorocarbons: HFC-134a and HCFC 123. Washington, DC: National Academy Press. NRC (National Research Council). 2004. Hydrogen fluoride acute exposure guideline levels. Pp. 123-197 in Acute Exposure Guideline Levels for Selected Airborne Chemicals, Vol. 4. Washington, DC: National Academies Press. Ohukuzi, S. 1966. Effect of muscular exercise on adrenaline and noradrenaline secretion of the adrenal gland in the dog. Tohoku J. Exp. Med. 88(4):361-366. Orion Safety Industries Pty Ltd. 2000. Triodide Gas Systems, Safety of Gaseous Extinguishing Products. [Online]. Available: http://www.orionsafety.com.au/product/triodide/paper1.html [accessed June 14, 2004]. Price, H.L., A.A. Lurie, R.E. Jones, M.L. Price, and H.W. Linde. 1958. Cyclopropane anesthesia. II. Epinephrine and norepinephrine in initiation of ventricular arrhythmias by carbon dioxide inhalation. Anesthesiology 19(5):619-630. Pritchard, J.B., J.E. French, B.J. Davis, and J.K. Haseman. 2003. The role of transgenic mouse models in carcinogen identification. Environ Health Perspect. 111(4):444-454. PTCL (Physical and Theoretical Chemistry Laboratory). 2003. Safety (MSDS) data for trifluoromethyl iodide. The Physical and Theoretical Chemistry Laboratory Oxford University Chemical and Other Safety Information. [Online]. Available: http://ptcl.chem.ox.ac.uk/MSDS/TR/trifluoromethyl_iodide.html [accessed July 19, 2004]. PTCL (Physical and Theoretical Chemistry Laboratory). 2003. Safety (MSDS) data for trifluoromethyl iodide. The Physical and Theoretical Chemistry Laboratory Oxford University Chemical and Other Safety Information. [Online]. Available: http://ptcl.chem.ox.ac.uk/MSDS/TR/trifluoromethyl_iodide.html [accessed July 19, 2004]. Purchase, I.F. 1966. Cardiac arrhythmias occurring during halothane anaesthesia in cats. Br. J. Anaesth. 38(1):13-22. Reinhardt, C.F., A. Azar, M.E. Maxfield, P.E. Smith Jr., and L.S. Mullin. 1971. Cardiac arrhythmias and aerosol “sniffing.” Arch. Environ. Health 22(2)265-279. Reinhardt, C.F, L.S. Mullin, and M.E. Maxfield. 1973. Epinephrine-induced cardiac arrhythmia potential of some common industrial solvents. J. Occup. Med. 15(12):953-955. Reynolds, A.K. 1983. Cardiac arrhythmias in sensitized hearts: Primary mechanisms involved. Res. Commun. Chem. Pathol. Pharmacol. 40(1):3-14. Rothenberg, S.J., R.M. Parker, R.G. York, G.E. Dearlove, M.M. Martin, K.H.

OCR for page 68
Iodotrifluoromethane: Toxicity Review Denny, S.D. Lief, A.M. Hoberman, and M.S. Christian. 2000. Lack of effects of nose-only inhalation exposure on testicular toxicity in male rats. Toxicol. Sci. 53(1):127-134. Rupnik, J., R.G. Bowman, and P. Berrill. 2002. Suitability of CF3I to Replace Halon 1301 as the Inerting Agent in Wing Fuel Tanks on the F-16 Aircraft. Prepared by HydroGeoLogic, Inc., Herndon, VA, for Defense Research and Engineering. September 30. Skaggs, S.R., and Cecil, M.A. 1995. Pp. 561-569 in Exposure Assessment to Triodide in Streaming Scenarios. Proceedings of International CFC and Halon Alternatives Conference, Washington, DC Solomon, S., J.B. Burkholder, A.R. Ravishankara, and R.R. Garcia. 1994. Ozone depletion and global warming potentials of CF3I. J. Geophys. Res. 99(D10):20929-20936. Tapscott, R.E. 1999. Best values of cup-burner extinguishing concentrations. Pp. 265-274 in Proceedings of Halon Options Technical Working Conference April 27-29, 1999, Albuquerque, NM. Center for Global Environmental Technologies, New Mexico Engineering Research Institute, Albuquerque. [Online]. Available: http://www.bfrl.nist.gov/866/HOTWC/HOTWC2003/pubs/R9902727.pdf [accessed June 15, 2004]. Trochimowicz, H.J., A. Azar, J.B. Terrill, and L.S. Mullin. 1974. Blood levels of fluorocarbon related to cardiac sensitization: II. Am. Ind. Hyg. Assoc. J. 35(10):632-639. Vinegar, A., and G.W. Jepson. 1996. Cardiac sensitization thresholds of halon replacement chemicals predicted in humans by physiologically-based pharmacokinetic modeling. Risk Anal. 16(4):571-579. Vinegar, A., G.W. Jepson, and J.H. Overton. 1998. PBPK modeling of short-term (0 to 5 min) human inhalation exposures to halogenated hydrocarbons. Inhal. Toxicol. 10(5): 411-429. Vinegar, A., G.W. Jepson, S.J. Hammann, G. Harper, D.S. Dierdorf, and J.H. Overton. 1999. Simulated blood levels of CF3I in personnel exposed during its release from an F-15 jet engine nacelle and during intentional inhalation. Am. Ind. Hyg. Assoc. J. 60(3):403-408. Vinegar, A., G.W. Jepson, M. Cisneros, R. Rubenstein, and W.J. Brock. 2000. Setting safe acute exposure limits for halon replacement chemicals using physiologically based pharmacokinetic modeling. Inhal. Toxicol. 12(8):751-763. Vitali, J. 2003. Potential Military Uses of CF3I. Paper presented to the Subcommittee on Iodotrifluoromethane, Washington, DC, October 28. Wickham, R.T. 2002. Status of Industry Efforts to Replace Halon Fire Extinguishing Agents. Wickham Associates, Stratham, NH. [Online]. Available: http://www.epa.gov/ozone/snap/fire/status.pdf [accessed July 28, 2004].